Effect of imexon treatment on friend virus complex infection using genetically defined mice as a model for HIV-1 infection

Antiviral Research

Volumn 15, Issue 1, 1991, Pages 51-65

  Morrey, John D ^a   Warren, Reed P ^a   Okleberry, Kevin M ^a   Burger, Roger A ^a   Chirigos, Michael A ^b   Sidwell, Robert W ^a  

^a UTAH STATE UNIVERSITY   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

AIDS; Friend virus; Genetically; HIV 1; Imexon; Model

Indexed keywords

ANTIVIRUS AGENT; IMEXON; PLACEBO;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; FRIEND LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMAL; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CELL COUNT; FEMALE; FRIEND MURINE LEUKEMIA VIRUS; HEXANONES; HIV-1; LEUKEMIA, EXPERIMENTAL; LYMPHOCYTES; MALE; MICE; MICE, INBRED STRAINS; MODELS, GENETIC; PHYTOHEMAGGLUTININS; RNA, VIRAL; SPLENOMEGALY; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA; FRIEND MURINE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MURINAE;

EID: 0026022724     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(91)90040-X     Document Type: Article

References (24)

1. HIV-1-specific B cell activation: A major constituent of spontaneous B cell activation during HIV-1 infection
2. BM 06 002: A new immunostimulating compound
3. Animal experiments on the compensation of the immunosuppressive action of cyclophosphamide by 2-[-2-cyanaziridinyl-(1)-]-2-[-2-carbamoylaziridinyl-(1)]-propane BM 12 531
4. Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice
5. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line
6. T-cell lymphoma model for the analysis of interleukin-1-mediated T-cell activation
7. Stimulation of regulatory T cell circuits by immunoglobulin-dependent structures on activated B cells
8. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor
9. Phase I and II study of BM 06 002, a new immunostimulating compound for cancer patients
10. Modulation of human lymphocytotoxicity by biological response modifiers
11. Hybridization of nucleic acids immobilized on solid supports
12. r/s genotype-containing mice used as a model for HIV infection
13. Influence of the murine MHC (H-2) on Friend leukemia virus-induced immunosuppression
14. Transforming genes and target cells of murine spleen focus-forming viruses
15. Other agents in the treatment of AIDS
16. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells
17. Use of disposable micro-tissue culture plate for antiviral and interferon induction studies
18. Effect of host weight loss on Friend leukemia virus infections in Swiss, DBA/2, and BALB/c mice
19. Use of a focal immunofluorescence assay on live cells for quantification of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses
20. Nested analysis of variance
21. Friend leukemia complex infection of mice as an experimental model for AIDS studies
22. Activation of suppressor T cells during Epstein-Barr virus-induced infectious mononucleosis
23. Replication of retroviruses
24. Deficient immune function of peripheral blood mononuclear cells from patients with Gardner syndrome